Actinium Pharmaceuticals Inc (ATNM)
Healthcare
Biotechnology
0.84 $
+0.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Actinium Pharmaceuticals Inc (ATNM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -5.9 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14 | -11 | -7.5 | -7.4 | -8.0 | -12 | -5.8 | -7.6 | -5.4 | -6.3 | -5.3 | -5.9 | -23 | |
| 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.8 | |
| 1.0 | 0.9 | 0.9 | 1.4 | 1.4 | 1.3 | 1.2 | 8.9 | 0.2 | 0.1 | 0.0 | 0.0 | 0.3 | |
| 1.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.3 | 1.0 | 0.7 | -0.3 | 1.8 | -1.9 | -0.5 | -0.7 | 1.1 | -1.5 | 0.4 | -0.6 | -0.6 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | |
| 0.0 | 0.0 | – | 0.0 | – | – | – | – | – | – | -0.1 | 0.0 | – | |
| 0.3 | – | – | – | – | – | – | – | – | -0.2 | – | – | – | |
| 0.0 | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 10 | 2.9 | 1.2 | 15 | 10.0 | 4.6 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | -0.2 | |
| -3.6 | -8.3 | -6.3 | 7.4 | 2.0 | -7.4 | -5.8 | -7.6 | -5.4 | -6.5 | -5.4 | -5.9 | -23 | |
| -14 | -11 | -7.5 | -7.4 | -8.0 | -12 | -5.8 | -7.6 | -5.4 | -6.3 | -5.4 | -5.9 | -23 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.